Sanofi US

208 articles about Sanofi US

• Sanofi-Aventis Appoints Euro RSCG Worldwide, Part Of The Havas Group, As One Of Its Two Strategic Communication Partners, And Now Becomes One Of Havas' Top Three Clients

  11/17/2006

• FDA Approves Sanofi-Aventis Allegra(R) (fexofenadine hydrochloride) Oral Suspension For Treatment Of Seasonal Allergy Symptoms And Chronic Idiopathic Urticaria

  10/19/2006

• UCB Group And Sanofi-Aventis (France) Sign A Co-Promotion Agreement For Xyzal(R); In The United States

  9/25/2006

• Cheaper Blood Thinner Just As Effective, Study Says

  8/23/2006

• Sanofi-Aventis (France): Release Of First Half 2006 Sales & Earnings - Wednesday August 2, 2006

  7/21/2006

• Sanofi-Aventis (France) Defends Ambien Sleeping Pill

  3/23/2006

• Sanofi-Aventis (France) Ambien May Prompt Sleep-Eating

  3/15/2006

• Ingenuity Systems Expands Scope Of Licensing Agreement With Sanofi-Aventis (New Jersey)

  3/7/2006

• World Health Organization Calls For Halt On Malaria Treatment

  1/19/2006

• Sanofi-Aventis (France) Release: Study Shows That Intra-Articular Hyaluronate Therapy Hyalgan(R) (sodium hyaluronate) Is Effective In Treating Chronic Shoulder Pain Due To Osteoarthritis

  11/15/2005

• Sanofi-Aventis Japan To Merge Sanofi-Synthelabo And Aventis Pharma Japan In January

  11/2/2005

• Europe Suspends Sanofi-Aventis Vaccine On Efficacy Concern

  9/20/2005

• Doubts Over "Metabolic Syndrome" Weigh On Sanofi

  8/25/2005

• Aventis Pharma Obtains Additional Approval for Taxoid Antitumor Agent TAXOTERE Injection

  8/22/2005

• P&G, Sanofi Aventis: The U.S. Food And Drug Administration Approves Actonel(R) With Calcium

  8/15/2005

• Sanofi-Aventis Release: ALLEGRA-D(R) 24 Hour Extended Release Tablets Now Available For Seasonal Allergy Sufferers

  7/28/2005

• Sanofi-Aventis Release: Lovenox(R) Patent Trial Update

  6/16/2005

• Sanofi-Aventis Release: Lantus(R) Add-On To Oral Monotherapy Therapy Showed Improved Glycemic Control In Type 2 Diabetes Patients Compared To Oral Actos Add-On To Oral Therapy

  6/13/2005

• Sanofi-Aventis Release: Clinical Study Results Demonstrated Greater Flexibility With Mealtime Dosing Of Apidra(R) When Compared To Regular Human Insulin

  6/13/2005

• Docetaxel Lowers Death Rate For Breast Cancer

  6/2/2005